TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,038,302 | +156.3% | 2,200,278 | +160.3% | 0.00% | +300.0% |
| Q2 2023 | $13,281,630 | -37.9% | 845,425 | -34.8% | 0.00% | -50.0% |
| Q1 2023 | $21,371,880 | +59.9% | 1,296,837 | +51.4% | 0.00% | 0.0% |
| Q4 2022 | $13,366,663 | -7.1% | 856,837 | -22.8% | 0.00% | 0.0% |
| Q3 2022 | $14,387,000 | +21.0% | 1,109,256 | +31.0% | 0.00% | +100.0% |
| Q2 2022 | $11,887,000 | -75.5% | 846,615 | -75.0% | 0.00% | -80.0% |
| Q1 2022 | $48,515,000 | +12.8% | 3,387,908 | +7.3% | 0.01% | +25.0% |
| Q4 2021 | $43,026,000 | -35.4% | 3,156,640 | -22.4% | 0.00% | -42.9% |
| Q3 2021 | $66,626,000 | +84.0% | 4,067,496 | +89.1% | 0.01% | +75.0% |
| Q2 2021 | $36,207,000 | -25.5% | 2,151,354 | -19.2% | 0.00% | -20.0% |
| Q1 2021 | $48,601,000 | +38.3% | 2,661,644 | +37.9% | 0.01% | 0.0% |
| Q4 2020 | $35,136,000 | -38.4% | 1,930,518 | -39.7% | 0.01% | -37.5% |
| Q3 2020 | $57,069,000 | +2.7% | 3,198,957 | +3.3% | 0.01% | 0.0% |
| Q2 2020 | $55,546,000 | +19.4% | 3,097,963 | +1.1% | 0.01% | 0.0% |
| Q1 2020 | $46,519,000 | -40.4% | 3,064,504 | -22.6% | 0.01% | -27.3% |
| Q4 2019 | $78,116,000 | +12.2% | 3,959,252 | -2.2% | 0.01% | +10.0% |
| Q3 2019 | $69,605,000 | +5.1% | 4,046,879 | +8.1% | 0.01% | 0.0% |
| Q2 2019 | $66,240,000 | +35.4% | 3,742,366 | +55.8% | 0.01% | +25.0% |
| Q1 2019 | $48,920,000 | -57.8% | 2,401,594 | -65.2% | 0.01% | -60.0% |
| Q4 2018 | $116,033,000 | – | 6,898,473 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |